| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 13913-008-12 | 13913-008 | HUMAN PRESCRIPTION DRUG | ZIPSOR | diclofenac potassium | CAPSULE, LIQUID FILLED | ORAL | 20151201 | N/A | NDA | NDA022202 | Assertio Therapeutics, Inc. | DICLOFENAC POTASSIUM | 25 mg/1 | 120 CAPSULE, LIQUID FILLED in 1 BOTTLE (13913-008-12) |
| 69315-275-20 | 69315-275 | HUMAN PRESCRIPTION DRUG | Diclofenac Potassium | Diclofenac Potassium | CAPSULE, LIQUID FILLED | ORAL | 20220324 | N/A | NDA AUTHORIZED GENERIC | NDA022202 | Leading Pharma, LLC | DICLOFENAC POTASSIUM | 25 mg/1 | 120 CAPSULE, LIQUID FILLED in 1 BOTTLE (69315-275-20) |